Video
What characteristics will the probiotics of the future have? We asked Antonio Gasbarrini, director of CEMAD at the Policlinico Gemelli.
Travis Whitfill, Co-Founder and CSO of Azitra, explains how Staphylococcus epidermidis-based products may treat various skin conditions and diseases.
Alan G. Wade, the founder of CPS Research, talks about how they analyze the microbiota to assess the impact of probiotics on health.
In precision cancer care, the microbiota cannot be put aside. We talked about this with James Kinross from the Imperial College London.
Antonio Gasbarrini from the Gemelli Hospital in Rome explains how the modulation of the intestinal microbiota is entering medicine.
Probiotics: 2019 will be crucial for scientific and regulatory aspects with help coming also from Venture Capital. Denise Kelly from Seventure talks about it.
The development of probiotics presents major regulatory challenges. We discussed it this Clara Desvignes from Voisin Consulting Life Sciences.
MetaboGen is active in the field of live biotherapeutic products and on the study of liver diseases. We discussed their approach with Sara Malcus, CEO of the company.
New technologies such as the analysis of the "aquatic microbiota" allow to dig deeply into the microbiome chemistry. We discuss this approach with Ross Youngs, CEO of Biosortia.
Prof. Lars Engstrand from the Karolinska Institutet, in Stockholm, Sweden, explains how studying the vaginal microbiota could impact on reproductive medicine.
